MabSolys is a private biotechnology company specialized in the field of antibodies R&D. Settled on the Biopark Genopole(R) (Evry, France), MabSolys benefits an ideal environment with privileged access to ISO-certified animal facilities of CERFE.

MABSOLUT / CRO Department

Through its dedicated CRO department “MAB’Solut” (www.mabsolut.com),  MabSolys provides a large variety of customized and high added-value services for the innovative research projects of its partners and clients, as part of a comprehensive and complete offer:

  1. Design and optimization of the antigens,
  2. Antibodies creation and screening,
  3. Biochemical and immunological characterization,
  4. Production and purification,
  5. Customized engineering (binding optimization, fragments, chimerization, humanization, etc.),
  6. Tests development,
  7. In-vivo experiments (proof of concept, efficacy, pre-tox and pharmacokinetics studies).

More than 20 customers are working with MAB’Solut department.


On the other hand, the company is currently establishing its early-stage products pipeline, which will cover the field of monoclonal antibodies for therapeutics as well as diagnostics / theranostics / biomarkers uses, on the basis of innovative and specific targets.

Our expertise stems from 15 years of R&D for antibodies.

We perfectly master each step of the antibody development process, from antigen definition and preparation, up to in vitro tests and in vivo studies.